CME [CME] vs Intercontinental [ICE] Detailed Stock Comparison
CME
NASDAQ
Loading...
Intercontinental
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: CME wins in 14 metrics, Intercontinental wins in 6 metrics, with 0 ties. CME appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CME | Intercontinental | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.52 | 34.15 | CME |
| Price-to-Book Ratio | 3.55 | 3.58 | CME |
| Debt-to-Equity Ratio | 13.60 | 68.94 | CME |
| PEG Ratio | 1.70 | 26.40 | CME |
| EV/EBITDA | 22.08 | 20.02 | Intercontinental |
| Profit Margin (TTM) | 58.59% | 31.00% | CME |
| Operating Margin (TTM) | 66.87% | 51.40% | CME |
| EBITDA Margin (TTM) | 66.87% | 51.40% | CME |
| Return on Equity | 13.61% | 11.06% | CME |
| Return on Assets (TTM) | 1.74% | 2.12% | Intercontinental |
| Free Cash Flow (TTM) | $3.60B | $3.86B | Intercontinental |
| Dividend Yield | 4.30% | 1.03% | CME |
| 1-Year Return | 31.12% | 11.41% | CME |
| Price-to-Sales Ratio (TTM) | 15.35 | 10.51 | Intercontinental |
| Enterprise Value | $100.39B | $120.60B | Intercontinental |
| EV/Revenue Ratio | 15.61 | 12.45 | Intercontinental |
| Gross Profit Margin (TTM) | 86.90% | 56.07% | CME |
| Revenue per Share (TTM) | $18 | $17 | CME |
| Earnings per Share (Diluted) | $10.33 | $5.21 | CME |
| Beta (Stock Volatility) | 0.46 | 1.12 | CME |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
CME vs Intercontinental Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CME | 1.10% | -1.59% | -1.28% | -2.32% | 8.27% | 16.66% |
| Intercontinental | 1.73% | -2.45% | -1.40% | 0.86% | 6.77% | 19.37% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CME | 31.12% | 38.27% | 53.36% | 186.93% | 428.70% | 404.63% |
| Intercontinental | 11.41% | 72.09% | 68.88% | 283.54% | 815.61% | 2,446.71% |
Performance & Financial Health Analysis: CME vs Intercontinental
| Metric | CME | ICE |
|---|---|---|
| Market Information | ||
| Market Cap | $98.72B | $101.86B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 1,887,200 | 3,323,740 |
| 90 Day Avg. Volume | 2,111,473 | 2,727,573 |
| Last Close | $274.47 | $181.35 |
| 52 Week Range | $206.44 - $290.79 | $142.29 - $189.35 |
| % from 52W High | -5.61% | -4.22% |
| All-Time High | $290.79 (Jun 02, 2025) | $189.35 (Aug 08, 2025) |
| % from All-Time High | -5.61% | -4.22% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.10% |
| Quarterly Earnings Growth | 0.16% | 0.35% |
| Financial Health | ||
| Profit Margin (TTM) | 0.59% | 0.31% |
| Operating Margin (TTM) | 0.67% | 0.51% |
| Return on Equity (TTM) | 0.14% | 0.11% |
| Debt to Equity (MRQ) | 13.60 | 68.94 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $77.13 | $49.73 |
| Cash per Share (MRQ) | $5.82 | $1.75 |
| Operating Cash Flow (TTM) | $4.20B | $4.88B |
| Levered Free Cash Flow (TTM) | $2.92B | $3.98B |
| Dividends | ||
| Last 12-Month Dividend Yield | 4.30% | 1.03% |
| Last 12-Month Dividend | $11.85 | $1.86 |
Valuation & Enterprise Metrics Analysis: CME vs Intercontinental
| Metric | CME | ICE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.52 | 34.15 |
| Forward P/E | 26.41 | 26.40 |
| PEG Ratio | 1.70 | 26.40 |
| Price to Sales (TTM) | 15.35 | 10.51 |
| Price to Book (MRQ) | 3.55 | 3.58 |
| Market Capitalization | ||
| Market Capitalization | $98.72B | $101.86B |
| Enterprise Value | $100.39B | $120.60B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 15.61 | 12.45 |
| Enterprise to EBITDA | 22.08 | 20.02 |
| Risk & Other Metrics | ||
| Beta | 0.46 | 1.12 |
| Book Value per Share (MRQ) | $77.13 | $49.73 |
Financial Statements Comparison: CME vs Intercontinental
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CME | ICE |
|---|---|---|
| Revenue/Sales | $1.64B | $3.23B |
| Cost of Goods Sold | $206.70M | $1.45B |
| Gross Profit | $1.44B | $1.78B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $1.11B | $1.25B |
| EBITDA | $476.30M | $1.69B |
| Pre-Tax Income | $1.24B | $1.07B |
| Income Tax | $288.60M | $255.00M |
| Net Income (Profit) | $956.20M | $812.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CME | ICE |
|---|---|---|
| Cash & Equivalents | $1.41B | $783.00M |
| Total Current Assets | $123.45B | $92.64B |
| Total Current Liabilities | $121.42B | $92.72B |
| Long-Term Debt | $3.42B | $17.69B |
| Total Shareholders Equity | $27.03B | $28.04B |
| Retained Earnings | $4.69B | $18.59B |
| Property, Plant & Equipment | $371.20M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CME | ICE |
|---|---|---|
| Operating Cash Flow | $838.30M | $1.05B |
| Capital Expenditures | $-14.20M | N/A |
| Free Cash Flow | $1.10B | $777.00M |
| Debt Repayment | $-750.00M | $-96.00M |
| Common Stock Repurchase | N/A | $-336.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CME | ICE |
|---|---|---|
| Shares Short | 5.42M | 6.35M |
| Short Ratio | 2.53 | 2.87 |
| Short % of Float | 0.02% | 0.01% |
| Average Daily Volume (10 Day) | 1,887,200 | 3,323,740 |
| Average Daily Volume (90 Day) | 2,111,473 | 2,727,573 |
| Shares Outstanding | 359.61M | 574.18M |
| Float Shares | 358.78M | 567.94M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.92% | 0.94% |
Dividend Analysis & Yield Comparison: CME vs Intercontinental
| Metric | CME | ICE |
|---|---|---|
| Last 12-Month Dividend | $11.85 | $1.86 |
| Last 12-Month Dividend Yield | 4.30% | 1.03% |
| 3-Year Avg Annual Dividend | $10.10 | $1.73 |
| 3-Year Avg Dividend Yield | 0.91% | 0.34% |
| 3-Year Total Dividends | $30.30 | $5.20 |
| Ex-Dividend Date | Sep 09, 2025 | Jun 13, 2025 |